Personal Information
Organization / Workplace
Egypt Egypt
Occupation
professor of pharmacology-benha university at October Pharma
Industry
Medical / Health Care / Pharmaceuticals
Contact Details
Tags
probiotics
prebiotics
t cells
microbiata functions
limitation
mechanism
dysbiosis
microbiate development
enhanced permeability
risk
approved nanomedicines
photothermal
cartilage-bone
nanotechnologyin cancer
tissue enginering
diagnostic nanoparticle
pharmacokinetics / biodistribu
surface modification
nanoparticle structure - types
proteasome inhibitor
transporters
apolipoprotein
lipoprotein
cholesterol metabolism
postbiotics
symbiotic
faecal transplantation
microbiome-modulation
diagnosis
microbiota in health and disea
development
human microbiome project
methods
microbiota composition
diagnostic markers
microbiota in diseases
microbiata and immunity
crispr gene therapy
comparison
need to know
who
ema
biomimics
heterogeneity
definition
analytical studies
comparative
immunigicity
clinical studies
manufacturing process
regulatory pathwway
biologics
biosimilar
intended copies
approved fda
prescriber
viral vectors
types of nucleases
gene therapy
rna therapy
transcription factors modulato
epigenetic modulation
epigenetic
non-coding rna
dna -genes structure
mesenchmal stem cells
durable β cell replacement
cancer immunotherapy
monocyte cells
natural kiling cells
dendertic cells
tissue-engineered
stem cells
somatic cell
intestinal microbiota-immunity
antibiotc diarrhea
enfant colic
charactarestic
bb-12
bifidobacterium
anticancer
antibiotic
environmental approach
risk-related of nanoro
hallenges
biologics and genes
pharmaceuticals. delivery
biomedical purposes
precision medicine
biosensors
nanorobot components
nanorobot types structures
pharmacological
molecular chaperones
proteostasis)
protein homeostasis
proteostasis
fecal microbiata transplantati
exercise
symbiotics
biomarkers
microbiota diversity
symbiosis
gut microbiome
the human microbiome project
transplantation immunity
innate immune response
lymphoid
microbiome-immunity interactio
host and the gut microbiome
drugs
factors control bone
opg
rank ligand
osteoclast
osteocyte
osteoblast
bone diseases
osteoporosis
calcium metabolism
small interfernce rna
monoclonal antibodies
antisense
antidyslipidemic drugs
atherosclerosis
hypertriglycerdemia
hyperlipidemia
receptors-ldl
bone tissue
self-assembly (tesa)
bioink
bioprinting
3d cell culture (organoid)
3d
cell-based tissue
cell culture formats
regenerative medicine
cartilage enginering
photothermal gene therapy
nanoparticles
scaffold
parathyroid hormone
bisphosphonate
antibodies
vitamin d
drugs sclerostin
enymes
See more
- Presentations
- Documents
- Infographics